Á lódáil...
Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicology
Historically, patients with metastatic, persistent or recurrent cervical cancer had limited therapeutic options. Despite several Phase II/III clinical trials, the combination of cisplatin and paclitaxel remained the most effective chemotherapeutic regimen. In 2014, publication of Gynecologic Oncolog...
Na minha lista:
| Foilsithe in: | Future Oncol |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5613942/ https://ncbi.nlm.nih.gov/pubmed/25760973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.14.276 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|